Therapeutic efficacy of ramucirumab after lenvatinib for post-progression treatment of unresectable hepatocellular carcinoma.
Atsushi HiraokaTakashi KumadaToshifumi TadaChikara OgawaJoji TaniShinya FukunishiMasanori AtsukawaMasashi HirookaKunihiko TsujiToru IshikawaKoichi TakaguchiKazuya KariyamaEi ItobayashiKazuto TajiriNoritomo ShimadaHiroshi ShibataHironori OchiKazuhito KawataHidenori ToyodaHideko OhamaKazuhiro NousoAkemi TsutsuiTakuya NaganoNorio ItokawaKorenobu HayamaTaeang AraiMichitaka ImaiYohei KoizumiShinichiro NakamuraKojiro MichitakaYoichi HiasaMasatoshi Kudonull nullPublished in: Gastroenterology report (2020)
The anticipated therapeutic efficacy of ramucirumab for post-progression treatment following lenvatinib was not seen in our early experience.
Keyphrases